Work Here?
Industries
Data & Analytics
Biotechnology
Company Size
11-50
Company Stage
Series A
Total Funding
$32.1M
Headquarters
San Francisco, California
Founded
2021
Latch.bio offers a cloud-based platform for biotech companies to manage and analyze their data. It allows users to store unlimited raw data, enhancing collaboration and making data analysis faster and more accessible. The platform stands out by providing customizable data management without extensive infrastructure setup and ensuring high-level security for data processing. Latch.bio's goal is to help biotech firms accelerate their research and development milestones while reducing costs.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$32.1M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Competitive salary
Equity
Medical, dental, & vision insurance
As a first case-study, LatchBio, Inc. is releasing an accelerated version of nf-core/methylseq that uses the GPU aligner Arioc developed by Richard Wilton.
Having already raised over US$28 million, LatchBio is making waves in the world of data management and clinical research; read on to learn more about the company's innovative solutions and how they are helping researchers overcome common bottlenecks!
LatchBio founders: Alfredo Andere, Kenny Workman, and Kyle Giffin. LatchBioMost industries today are experiencing an unprecedented data deluge – and synthetic biology is no exception. Twenty years ago, a typical biological experiment generated 3-5 megabytes of information. Today, a routine synthetic biology workflow produces anywhere from 1,000 to 40,000 terabytes. That is a billion times more data! Such a large number of data points is simply impossible to interpret by human eye. This is why almost every bio lab today has to set up custom bioinformatics pipelines, invest in cloud computing, and master advanced data visualization software – all that just to see the results of their experiments.A San Francisco startup, LatchBio, hopes to make data analysis much easier for biologists with its full-stack biocomputing infrastructure
Biologists and other scientists are confronted these days with a deep sea of data and a bewildering panoply of tools to apply to it — many of which require a specialist to operate. Hiring one is a challenge and farming out the work may take months … but LatchBio offers an option that can have []
SAN FRANCISCO--(BUSINESS WIRE)-- #AI--LatchBio raises $28M Series A to bring modern data analysis stack to biologists
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Biotechnology
Company Size
11-50
Company Stage
Series A
Total Funding
$32.1M
Headquarters
San Francisco, California
Founded
2021
Find jobs on Simplify and start your career today